Details of the Drug Combinations

General Information of This Drug (ID: DMHJV0X)

Drug Name

Pertuzumab DMHJV0X

Synonyms

Pertuzumab (genetical recombination); Pertuzumab (USAN/INN); Pertuzumab (genetical recombination) (JAN); Pertuzumab (ERBB2 mAb inhibitor)

Indication

Disease Entry	ICD 11	Status	REF
Adrenal gland neoplasm	N.A.	Approved	[1]
Breast cancer	2C60-2C65	Approved	[2]
Neuroblastoma	2D11.2	Investigative	[1]
------------------------------------------------------------------------------------

Drug Type

Monoclonal antibody

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Pertuzumab + Trastuzumab	DC8DT7B	Trastuzumab	Breast cancer	[3]
------------------------------------------------------------------------------------

References

1	A standard database for drug repositioning. Sci Data. 2017 Mar 14;4:170029.
2	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5046).
3	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)